Zhitong Finance App News, Shenlian Biotech (688098.SH) issued an announcement. Recently, according to the “Veterinary Drug Administration Regulations”, “Veterinary Drug Product Approval Number Management Measures” and other relevant regulations, after review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, the Lanzhou branch of the company was authorized to produce a live porcine pseudorabies vaccine (JS-A1 strain) and issue approval documents for veterinary drug products.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.